EnteroMedics (ETRM) Announces Publication of Positive ReCharge Clinical Study Data
Tweet Send to a Friend
EnteroMedics Inc. (NASDAQ: ETRM) announced the publication of 24 month results from the Company's ReCharge Clinical Study. The article ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
